SCHEMBL1892802

SCHEMBL1892802

Cc1nc(-c2cc(C(=O)Nc3n[nH]c4c3CN(S(=O)(=O)c3cc(F)cc(F)c3)CC4)c(C(N)=O)cc2N2CCN(C)CC2)oc1C(=O)O

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IGF1R P08069 5/20 0.57
AURKA O14965 8/20 0.34
AURKB Q96GD4 5/20 0.34
NTRK1 P04629 3/20 0.32
NTRK3 Q16288 3/20 0.32
NTRK2 Q16620 2/20 0.32
ALK Q9UM73 6/20 0.32
INSR P06213 4/20 0.32
GAA P10253 2/20 0.32
ABL1 P00519 1/20 0.31
BCR P11274 1/20 0.31
PLK1 P53350 1/20 0.31
CCNA2 P20248 1/20 0.30
CDK2 P24941 1/20 0.30
CCNA1 P78396 1/20 0.30
PLK4 O00444 1/20 0.30
DAPK3 O43293 1/20 0.30
PRKCG P05129 1/20 0.30
ROS1 P08922 1/20 0.30
FER P16591 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1892886 0.90 IGF1R (0.44) IGF1RNTRK1NTRK3NTRK2ALK
SCHEMBL1888825 0.85 IGF1R (0.57) IGF1RAURKAAURKBNTRK1NTRK3
SCHEMBL1889843 0.83 IGF1R (0.62) IGF1RAURKAAURKBNTRK1NTRK3
SCHEMBL1887478 0.83 IGF1R (0.63) IGF1RAURKAAURKBNTRK1NTRK3
SCHEMBL1894810 0.82 IGF1R (0.61) IGF1RAURKAAURKBNTRK1NTRK3
SCHEMBL1887752 0.81 IGF1R (0.61) IGF1RAURKAAURKBNTRK1NTRK3
SCHEMBL1892955 0.81 IGF1R (0.52) IGF1RAURKAAURKBCCNA2CDK2
SCHEMBL1883600 0.80 IGF1R (0.59) IGF1RAURKAAURKBNTRK1NTRK3
SCHEMBL1889900 0.80 IGF1R (0.59) IGF1RAURKAAURKBNTRK1NTRK3
SCHEMBL1892782 0.80 IGF1R (0.59) IGF1RAURKAAURKBNTRK1NTRK3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110230470-A1 SUBSTITUTED PYRAZOLO[4,3-C]PYRIDINE DERIVATIVES ACTIVE AS KINASE INHIBITORS NERVIANO MEDICAL SCIENCES S.R.L. (IT) 2011-09-22 US disclosed
US-7947686-B2 Substituted pyrazolo[4,3-c]pyridine derivatives active as kinase inhibitors NERVIANO MEDICAL SCIENCES S.R.L. (IT) 2011-05-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110230470-A1 SUBSTITUTED PYRAZOLO[4,3-C]PYRIDINE DERIVATIVES ACTIVE AS KINASE INHIBITORS MAP3K3, MAP3K1, MAP3K19 IGF1R 760/4885AURKA 332/4885AURKB 431/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.